From an evolutionary perspective, all 'new' antimicrobial targets are old: time to think outside the box.
作者信息
Martin Jennifer H, Ferro Albert
机构信息
University of Queensland School of Medicine and Princess Alexandra Hospital, Brisbane, 4102, Queensland, Australia.
出版信息
Br J Clin Pharmacol. 2015 Feb;79(2):165-7. doi: 10.1111/bcp.12385.
Abstract
摘要
相似文献
1
From an evolutionary perspective, all 'new' antimicrobial targets are old: time to think outside the box.从进化的角度来看，所有“新的”抗菌靶点其实都很古老：是时候跳出框框思考了。
Br J Clin Pharmacol. 2015 Feb;79(2):165-7. doi: 10.1111/bcp.12385.
2
Druggability of the enzymes of the non-mevalonate-pathway.非甲羟戊酸途径中酶的可成药性
Drug Discov Today. 2013 Dec;18(23-24):1256-62. doi: 10.1016/j.drudis.2013.07.003. Epub 2013 Jul 13.
3
New targets and screening approaches in antimicrobial drug discovery.抗菌药物研发中的新靶点与筛选方法
Chem Rev. 2005 Feb;105(2):759-74. doi: 10.1021/cr030116o.
4
Anti-infective carbonic anhydrase inhibitors: a patent and literature review.抗感染碳酸酐酶抑制剂：专利和文献综述。
Expert Opin Ther Pat. 2013;23(6):693-704. doi: 10.1517/13543776.2013.778245. Epub 2013 Mar 14.
5
The need to redefine antimicrobial drug discovery.重新定义抗菌药物研发的必要性。
Curr Pharm Des. 2011;17(13):1223-4. doi: 10.2174/138161211795703762.
6
The future control of bacterial resistance to antimicrobial agents.细菌对抗菌药物耐药性的未来控制
Am J Infect Control. 2001 Aug;29(4):256-8. doi: 10.1067/mic.2001.115672.
7
Antimicrobial agents: the new theriac?抗菌药物：新的万灵药？
Expert Rev Anti Infect Ther. 2012 Dec;10(12):1363-5. doi: 10.1586/eri.12.144.
8
Strategies employed in the design and optimization of synthetic antimicrobial peptide amphiphiles with enhanced therapeutic potentials.设计和优化具有增强治疗潜力的合成抗菌肽两亲物的策略。
Adv Drug Deliv Rev. 2014 Nov 30;78:28-45. doi: 10.1016/j.addr.2014.10.013.
9
Incentives for developing new antibiotics or antimicrobial strategies.开发新型抗生素或抗菌策略的激励措施。
BMJ. 2013 Apr 8;346:f2136. doi: 10.1136/bmj.f2136.
10
[Computer searching of new targets for antimicrobial drugs based on comparative analysis of genomes].基于基因组比较分析的抗菌药物新靶点计算机搜索
Vopr Med Khim. 2001 May-Jun;47(3):353-67.
引用本文的文献
1
New Consensus Definitions for Sepsis and Septic Shock: Implications for Treatment Strategies and Drug Development?新的脓毒症和脓毒性休克定义共识：对治疗策略和药物研发的影响？
Drugs. 2017 Mar;77(4):353-361. doi: 10.1007/s40265-017-0698-0.
本文引用的文献
1
Meeting the societal need for new antibiotics: the challenges for the pharmaceutical industry.满足社会对新型抗生素的需求：制药行业面临的挑战。
Br J Clin Pharmacol. 2015 Feb;79(2):168-72. doi: 10.1111/bcp.12401.
2
Antimicrobial stewardship - can we afford to do without it?抗菌药物管理——我们能没有它吗？
Br J Clin Pharmacol. 2015 Feb;79(2):173-81. doi: 10.1111/bcp.12417.
3
The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.三十年抗逆转录病毒疗法的演进：挑战、成就与未来的前景
Br J Clin Pharmacol. 2015 Feb;79(2):182-94. doi: 10.1111/bcp.12403.
4
Anti-infective use in children and pregnancy: current deficiencies and future challenges.儿童及孕期抗感染药物的应用：当前不足与未来挑战
Br J Clin Pharmacol. 2015 Feb;79(2):216-21. doi: 10.1111/bcp.12363.
5
Targeting virulence not viability in the search for future antibacterials.在寻找未来抗菌药物时，以毒力而非生存能力为靶点。
Br J Clin Pharmacol. 2015 Feb;79(2):208-15. doi: 10.1111/bcp.12356.
6
The prevention and management of infections due to multidrug resistant organisms in haematology patients.血液学患者中多重耐药菌感染的预防与管理
Br J Clin Pharmacol. 2015 Feb;79(2):195-207. doi: 10.1111/bcp.12310.
7
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.抗 MD2 单克隆抗体（Eritoran）对严重脓毒症患者死亡率的影响：ACCESS 随机试验。
JAMA. 2013 Mar 20;309(11):1154-62. doi: 10.1001/jama.2013.2194.
8
The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trial.阿拉斯加原住民儿童侵袭性肺炎球菌病的 13 价肺炎球菌结合疫苗：临床试验结果。
Pediatr Infect Dis J. 2013 Mar;32(3):257-63. doi: 10.1097/INF.0b013e3182748ada.
9
After TGN1412: recent developments in cytokine release assays.TGN1412 事件后：细胞因子释放检测的最新进展。
J Immunotoxicol. 2013 Jan-Mar;10(1):75-82. doi: 10.3109/1547691X.2012.711783. Epub 2012 Sep 11.
10
Antibiotic resistance is prevalent in an isolated cave microbiome.抗生素耐药性在一个与世隔绝的洞穴微生物组中普遍存在。
PLoS One. 2012;7(4):e34953. doi: 10.1371/journal.pone.0034953. Epub 2012 Apr 11.
Zotero 插件